Cite

HARVARD Citation

    Garcia-Manero, G. et al. (2018). CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia. Leukemia research. pp. 79-85. [Online]. 
  
Back to record